We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
+137.87%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$667M
AUM Growth
+$315M
(+89%)
Cap. Flow
-$13.1M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Pharvaris
PHVS
|
+$13.3M |
Top Sells
| 1 |
VTYX
Ventyx Biosciences
VTYX
|
+$26.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZB
1
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $321M | 48.06% |
5,158,162
| – | – |
|
2
ALX Oncology
ALXO
$269M
| $144M | 21.65% |
9,699,925
| – | – |
|
|
3
Pharvaris
PHVS
$2.36B
| $138M | 20.68% |
4,919,504
+654,832
| +15% | +$13.3M |
|
4
Harmony Biosciences
HRMY
$1.93B
| $33.4M | 5.01% |
1,035,396
| – | – |
|
|
SLRN
5
DELISTED
ACELYRIN
SLRN
| $28.7M | 4.31% |
3,852,470
| – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $1.56M | 0.23% |
2,914,255
| – | – |
|
|
IMPL
7
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $341K | 0.05% |
2,759,791
| – | – |
|
|
VTYX
8
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-758,800
| Closed | -$26.4M |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM